|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.00 EUR | +4.29% |
|
+1.83% | +14.38% |
| 30/06 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.74TCr | |||||
| 5.4TCr | |||||
| 4.18TCr | |||||
| 4.11TCr | - | ||||
| 2.93TCr | - |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
